Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 05, 16:00
2870.15
-8.55 (-0.3%)
VOLUME 11,422
LIVE
NSE
Dec 05, 15:59
2871.60
-6.25 (-0.22%)
VOLUME 433,761
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
RIL has resistance at Rs 1040-1045: Shinde 

6.39 pm | 21 Dec 2009 |  Source: CNBC-TV18

Rohit Shinde, CD Equisearch is of the view that Reliance Industries (RIL) has resistance at Rs 1040-1045....

Dr Reddys Laboratories can test Rs 1303: Anu Jain 

10.40 am | 21 Dec 2009 |  Source: CNBC-TV18

Dr Reddys Laboratories can test Rs 1303, says Anu Jain, Vice President - IIFL Private Wealth Management, India Infoline....

Pressure on US, Germany sales, other mkts doing well: DRL 

10.54 am | 15 Dec 2009 |  Source: CNBC-TV18

In an interview with CNBC-TV18, GV Prasad, Vice Chairman and CEO, Dr Reddy Laboratories Limited spoke about the latest happenings in his company and s...

Pharma stocks may continue to outperform: Thacker 

5.52 pm | 11 Dec 2009 |  Source: CNBC-TV18

Pharma stocks may continue to outperform, says Technical Analyst, Mitesh Thacker of miteshthacker.com....

Dr Reddy's files for marketing Lipitor generic

12.53 pm | 07 Nov 2009 |  Source: Reuters

Dr Reddy's Laboratories has filed for marketing a generic version of Pfizer's cholesterol-lowering drug Lipitor in the U.S., the company said on Satur...

Dr Reddy's speaking to potential partners for bio-similars 

12.41 pm | 04 Nov 2009 |  Source: CNBC-TV18

GV Prasad of Dr Reddys said that the company is speaking to potential partners for bio-similars and may do a partnership deal next year. Vikas Dandek...

Dr Reddys Lab has target of Rs 1040-1050: Anu Jain 

10.46 am | 03 Nov 2009 |  Source: CNBC-TV18

Dr Reddys Laboratories has target of Rs 1040-1050, says Anu Jain, Vice President - IIFL Private Wealth Management, India Infoline....

Dr Reddy's Labs an outperformer, target of Rs 1200: Karvy

10.27 am | 29 Oct 2009 |  Source: Moneycontrol.com

Dr Reddy's Labs is an outperformer, says Karvy Stock Broking's report. ...

Dr Reddys Labs launches 5 new products in North America

7.09 pm | 23 Oct 2009 |  Source: Moneycontrol.com

Dr Reddys Laboratories has announced its second quarter results. The company's Q2 consolidated net profit was up 107% at Rs 217.3 crore versus Rs 105....

Dr Reddys Labs Q2 PAT up 107% at Rs 217.3 cr 

1.44 pm | 23 Oct 2009 |  Source: CNBC-TV18

Dr Reddys Laboratories has announced its second quarter results. The company's Q2 consolidated net profit was up at Rs 217.3 crore versus Rs 105.3 cro...

Pharma outlook: What's brewing at DRL, Lupin, Pfizer? 

12.32 pm | 23 Oct 2009 |  Source: CNBC-TV18/Mint

Vikas Dandekar, India Bureau Chief, PharmAsiaNews.Com provides his outlook on some the pharmaceutical comapnies. ...

Dr Reddys Labs Q2 net profit seen up 27% at Rs 154 cr

7.30 am | 23 Oct 2009 |  Source: CNBC-TV18

Dr Reddys Laboratories is to announce its second quarter results. According to CNBC-TV18 estimates, the companys consolidated IFRS Q2 FY10 net sales ...

Dr Reddys Labs has target of Rs 990: Sukhani 

10.11 am | 16 Oct 2009 |  Source: CNBC-TV18

Dr Reddys Labs has target of Rs 990, says Technical Analyst, Sudarshan Sukhani....

Dr Reddy's Labs an outperformer, target of Rs 1120: Karvy

4.39 pm | 14 Oct 2009 |  Source: Moneycontrol.com

Dr Reddy's Labs is an outperformer, says Karvy Stock Broking's report. ...

Dr Reddys Sept qtr PAT seen up at Rs 179.7 cr: M Oswal

2.26 pm | 10 Oct 2009 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earning estimates for Pharmaceutical sector for the quarter ended September 2009. According to the research firm, ...

Hold Dr Reddy's Labs, target Rs 961: Indiabulls Securities

4.29 pm | 07 Oct 2009 |  Source: Moneycontrol.com

Hold with a price target of Rs 961, says Indiabulls Securities' report. ...

Dr. Reddys Q2 net profit seen at Rs 139.1cr: Angel

12.01 pm | 06 Oct 2009 |  Source: Moneycontrol.com

Angel Broking has come out with its earning estimates for Pharma sector for the quarter ended September 2009. According to the research firm, Dr. Redd...

Buy Dr Reddy, Cipla, Ranbaxy on every dip: Sukhani 

2.07 pm | 03 Oct 2009 |  Source: CNBC-TV18

Dr Reddy, Cipla and Ranbaxy are worth buying on every correction, says Sudarshan Sukhani, Technical Analyst....

Exit Dr Reddys Lab; Baliga 

5.30 pm | 01 Oct 2009 |  Source: CNBC-TV18

Exit Dr Reddys Laboratories as it looks expensive, says Ambareesh Baliga of Karvy Stock Broking....

Dr Reddys looks good: Sukhani 

10.31 am | 30 Sep 2009 |  Source: CNBC-TV18

Dr Reddys is looking good, says Technical Analyst, Sudarshan Sukhani....

1 2 3 4
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.